• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy
  • Reports
    • Diabetes Technology Innovations Special Report
    • Continuous Glucose Monitoring (CGM) Market Report

Trinity Biotech

Trinity Biotech inks partnership to pair CGM+ with drug delivery system

July 22, 2026 By Sean Whooley

Latch Medical Pharma Latch Trinity Biotech CGM+

Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a strategic collaboration with drug delivery tech developer Latch Medical. Latch Medical develops Pharma Latch, an intradermal drug delivery platform. The hollow, microneedle-based intradermal drug delivery technology is designed to enable precise, reliable and repeatable delivery of injectable therapies into the skin. The company developed it […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Latch Medical, Trinity Biotech

Trinity Biotech reports positive clinical findings for next-gen CGM

July 2, 2026 By Sean Whooley

Trinity Biotech CGM+ components

Trinity Biotech (Nasdaq:TRIB) today announced new clinical findings supporting its next-generation continuous glucose monitor (CGM). Dublin, Ireland-based Trinity unveiled the CGM+ next-gen wearable biosensor in July 2025. With CGM+, the company aims to take on the growing AI wearables market. The company said it has the system in the later stages of device development. The new […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech expects pivotal trial for CGM+ in 2026, platform moves toward regulatory submissions

March 10, 2026 By Sean Whooley

Trinity Biotech CGM+ slim

Trinity Biotech (Nasdaq:TRIB) today provided an update on the expected timeline for its CGM+ continuous glucose monitoring (CGM) system. Dublin, Ireland-based Trinity unveiled the CGM+ next-gen wearable biosensor in July 2025. With CGM+, the company aims to take on the growing AI wearables market. The company said it has the system in the later stages […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech raises $25M as it looks to advance CGM+ system

February 25, 2026 By Sean Whooley

Trinity Biotech CGM+ slim

Trinity Biotech (Nasdaq:TRIB) announced today that it entered into a $25 million Standby Equity Purchase Agreement (SEPA). The agreement with an affiliate of financing partner Yorkville Advisors Global provides the Dublin, Ireland-based company with additional funding to augment its commercialization initiatives and support its R&D programs. Under the SEPA, Trinity has the right, but not […]

Filed Under: Business/Financial News, Diabetes, Featured, Funding Roundup, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech reports positive outcomes with next-gen CGM sensor

August 12, 2025 By Sean Whooley

Trinity Biotech CGM+ slim

Trinity Biotech (Nasdaq:TRIB) today announced positive clinical trial results for its next-generation continuous glucose monitor (CGM). Dublin, Ireland-based Trinity Biotech unveiled its CGM+ next-gen wearable biosensor last month. With CGM+, the company aims to take on the growing AI wearables market. The company said it has the system in the later stages of device development. […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech unveils next-gen AI-powered CGM biosensor

July 24, 2025 By Sean Whooley

Trinity Biotech CGM+

Trinity Biotech (Nasdaq:TRIB) announced today that it unveiled its new flagship continuous glucose monitor (CGM) biosensor system. CGM+, a next-gen wearable biosensor, aims to take on the growing AI wearables market. The Dublin, Ireland-based company said it has the system in the later stages of device development. The new AI-native CGM combines multi-sensor data with […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech to undergo strategic realignment, focus on CGM development

March 13, 2025 By Sean Whooley

Trinity Biotech Logo

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a continuous glucose monitor (CGM) to market. Dublin, Ireland-based Trinity Biotech appointed Barclays as its exclusive financial advisor to support an ongoing strategic realignment. The company aims to increase its focus on its “disruptive” CGM technology as part […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech expects to submit ‘disruptive’ next-gen CGM to FDA in 2026

February 1, 2025 By Sean Whooley

Trinity Biotech Logo

Trinity Biotech (Nasdaq:TRIB) announced new pre-pivotal clinical data supporting its next-generation continuous glucose monitor (CGM) system. Dublin, Ireland-based Trinity’s trial included 30 participants, primarily with type 1 diabetes. The company said it represents a significant milestone in its mission to deliver high-performance CGM technology. Its study highlighted the system’s signal quality, accuracy and more. The […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Trinity Biotech completes pre-pivotal study of next-gen CGM

October 7, 2024 By Sean Whooley

Trinity Biotech Logo

Trinity Biotech today announced that it completed the first pre-pivotal clinical trial in Europe for its next-generation CGM technology. The study assessed the analytical performance of continuous glucose monitoring (CGM) technology enhancements implemented by Trinity. Dublin, Ireland-based Trinity added the improvements to the CGM technology it acquired from Waveform Technologies in January. Trinity implemented an […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Trinity Biotech

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.
MDO

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
About
Contact us
Listen to our Weekly Podcasts
Advertise

Copyright © 2026 · Arrowfly LLC. All Rights Reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy | Terms & Conditions | RSS